Brief: Oncopeptides Suggests No Dividend For 2025
19/02/2026 07:16
Feb 19 (Reuters) - Oncopeptides AB ONCO.ST: ONCOPEPTIDES Q4 OPERATING PROFIT SEK -61.53 MILLION ONCOPEPTIDES Q4 SALES SEK 18.567 MILLION ONCOPEPTIDES Q4 ADJUSTED EPS SEK -0.25 ONCOPEPTIDES Q4 ADJUSTED FREE CASH FLOW SEK -60.064 MILLION ONCOPEPTIDES Q4 NET INCOME SEK -65.173 MILLION NO DIVIDEND IS SUGGESTED FOR FISCAL YEAR 2025 Source text: ID:nMFN9vWYP6 Further company coverage: ONCO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy